Impact Stories

PRINCIPLE study shows asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

By 14 April 2021April 19th, 2021No Comments
Young female in white t-shirt using blue asthma inhaler for relief asthma attack. Pharmaceutical products is used to prevent and treat wheezing and shortness of breath caused asthma or COPD. Close up.

26 general practices in Bradford (102 in West Yorkshire) are participating in the PRINCIPLE study, investigating possible treatments for non-hospitalised COVID-19 patients.

The study has released findings this week demonstrating that the asthma drug budesonide reduced recovery time in trial participants.

To read more, visit:…